Health ❯Healthcare ❯Regulations

FDA

Drug Approval Process Drug Safety Drug Compounding Drug Approval Processes Good Manufacturing Practices Drug Shortages Current Good Manufacturing Practices Mifepristone Clinical Trials Drug Enforcement Compounding Pharmacies Compounded Medications Mammography Guidelines Stem Cell Therapy

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

FDA Audit Triggers Nationwide Recall of Over 75,000 Eye Care Products

Nationwide Recall of Eye Care Products Over Sterility Concerns

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

FDA Recalls Duloxetine Over Cancer-Causing Chemical Concerns

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market

CEO Sentenced to 3 Years for Selling Unapproved Stem Cell Treatments